Venture Capital

Verdiva Bio: Cardiometabolic Company Raises Over $410 Million (Series A)

By Amit Chowdhry ● Jan 10, 2025

Verdiva Bio announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. And the company is advancing a portfolio of next-generation oral and injectable treatments with first-in-class or best-in-class potential. And Verdiva has launched with an oversubscribed Series A funding of $411 million, co-led by Forbion and General Atlantic, with additional participation from RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, and LYFE Capital.

Oxford Cancer Analytics: $11 Million (Series A) Secured For Transforming Early Lung Cancer Detection And Enabling Curative Treatments

By Amit Chowdhry ● Jan 10, 2025

Oxford Cancer Analytics - a medical technology company developing blood tests for early cancer detection using advanced proteomics and AI - announced it has raised $11 million in Series A funding from global investors, such as in-field institutional investors in disease detection and diagnostics.

Earth First Food Ventures: Interview With Co-Founder & CEO Brian Ruszczyk About The ESG/Impact Focused Investment Firm

By Amit Chowdhry ● Jan 10, 2025

Earth First Food Ventures (EFFV) is a venture capital platform offering ESG/impact investing in innovative food technologies, mostly in the precision fermentation space, focusing on alternative dairy from precision fermentation. Pulse 2.0 interviewed Earth First Food Ventures co-founder and CEO Brian Ruszczyk to learn more.

Geneoscopy: $105 Million (Series C) Raised For Developing Advanced Gastrointestinal Diagnostic Tests

By Amit Chowdhry ● Jan 10, 2025

Geneoscopy - a life sciences company focused on developing diagnostic tests for advancing gastrointestinal health - announced the closing of a Series C funding round raising $105 million. Bio-Rad Laboratories led the financing and was joined by Petrichor, Labcorp, Morningside Ventures, Lightchain Capital, NT Investments, Granger Management and Mercy Health, Tri Locum Partners, and others.

Frontier Direct Care: Employer-Funded Healthcare Leader Closes $20 Million (Series B)

By Amit Chowdhry ● Jan 10, 2025

Frontier Direct Care, a leading innovator in employer-funded healthcare, announced the initial closing of its $20 million Series B funding round, led by Mehshah Capital. This funding will accelerate the company's mission to transform healthcare by delivering affordable and high-quality care to employees and their families.

Scrum Ventures Closes New Tech Fund At $68 Million

By Amit Chowdhry ● Jan 10, 2025

Scrum Ventures, an early-stage venture capital firm, announced the closing of its first vertically focused tech fund Scrum Sports & Entertainment Fund I (SSE). This new fund, which closed at $68 million, invests in technology companies that support the growth of the sports and entertainment sector but also transcend the vertical and address market inefficiencies in other industries.

Relief Cardiovascular: $12 Million (Series A) Raised To Develop Transcatheter Implants

By Amit Chowdhry ● Jan 10, 2025

Relief Cardiovascular, an inQB8 Medical Technologies portfolio company pioneering innovative solutions for the management of heart failure, announced the closing of a $12 million Series A funding round. This funding round was co-led by Broadview Ventures and Advent Life Sciences, with participation from Pacific Health Investment, Heartwork Capital, and an undisclosed multinational strategy.

Expansion Capital Group: $100 Million Credit Facility Secured For Accelerating Growth

By Amit Chowdhry ● Jan 10, 2025

Expansion Capital Group (ECG), a provider of working capital solutions for small businesses, announced the closing of a $100 million credit facility. And this achievement reinforces ECG’s dedication to empowering small businesses nationwide by delivering fast and dependable access to capital.

FTV: $4.05 Billion In Capital Commitments Raised

By Amit Chowdhry ● Jan 10, 2025

Growth equity investment firm FTV Capital announced the completion of its latest growth equity fundraising with $4.05 billion in capital commitments. And spanning two complementary funds – its eighth flagship fund (FTV VIII) and a new vehicle dedicated to smaller investments FTV Ascend I, the new funding enables FTV to expand its approach to supporting high-growth companies with equity checks ranging from $20 million to $300 million while maintaining a concentrated portfolio of investments in its funds.

Qualified Health: $30 Million (Seed) Raised For Developing GenAI Infrastructure In Healthcare

By Amit Chowdhry ● Jan 10, 2025

Qualified Health announced its launch with $30 million in seed funding to develop the infrastructure for generative AI in healthcare. The major investors are SignalFire, Healthier Capital, Town Hall Ventures, and Frist Cressey Ventures, with participation from Intermountain Ventures, Flare Capital Partners, and prominent healthcare and technology sector angels.

Flint Capital: Interview With Partner Andrew Gershfeld About The Early-Stage Investment Firm

By Amit Chowdhry ● Jan 10, 2025

Flint Capital is an early-stage venture capital fund that has invested in companies like Flo Health, Bluebricks, Sensi.AI, BlinqIO, Oneday, WalkMe, and Lending Club. Pulse 2.0 interviewed Flint Capital partner Andrew Gershfeld to learn more about the firm.

XOCEAN: Ocean Data Provider Company Raises €115 Million

By Amit Chowdhry ● Jan 10, 2025

XOCEAN, an ocean data provider to the offshore energy and civil hydrography sectors, announced it closed a €115 million fundraise that will help support its ongoing growth across the company's expanding global footprint. The company partnered with S2G Ventures (S2G) to structure the round, which was funded by S2G, Climate Investment (CI), Morgan Stanley's 1GT fund, and an affiliate of the Crown Family's CC Industries (CCI) - collectively known as the investor consortium.

Rena Labs: Autonomous And Verifiable AI Solutions Company Raises $3.3 Million

By Amit Chowdhry ● Jan 10, 2025

Rena Labs, a company aiming to enable the next generation of autonomous and verifiable AI solutions, announced closing a $3.3 million pre-seed funding round led by Paper Ventures. And the company attracted investment from several venture capital firms, including Lightspeed Faction, Eterna Capital, Lyrik Ventures, Mapleblock Capital, Selini Capital, Keyrock, and others.